{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T12:47:08Z","timestamp":1693313228217},"reference-count":26,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:sec>\n<jats:title>Background and Aim:<\/jats:title>\n<jats:p>Subclinical hypothyroidism (SCH) is frequently seen in diabetic\npatients. Elevated levels of uric acid (UA) were also reported in diabetic patients. No study assessed\nthe relation between SCH and UA levels in diabetic patients. We aimed to evaluate this relation\nand the association of both conditions with other clinical and laboratory parameters in diabetic\npatients.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Subjects and Methods:<\/jats:title>\n<jats:p>This cross-sectional study included 100 T2DM patients in addition to 50\nage and sex matched healthy controls. Diabetic patients comprised 50 patients with SCH and 50 euthyroid\npatients. All participants were subjected to careful history taking, thorough clinical examination\nand standard laboratory work up. The performed investigations included fasting and postprandial\nblood sugar, fasting insulin levels, HbA1c levels, thyroid hormones (FT3, FT4 and TSH),\nrenal profile and serum UA.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Comparison between the studied groups regarding serum UA levels revealed significantly\nhigher levels in the diabetic group (5.4 \u00b1 1.9 versus 4.2 \u00b1 1.0 mg\/dl, p&lt;0.001). SCH + DM patients\nhad significantly higher UA levels in comparison to DM group (6.1 \u00b1 1.8 versus 4.8 \u00b1 1.7 mg\/dl,\np&lt;0.001) and control group (6.1 \u00b1 1.8 versus 4.2 \u00b1 1.0 mg\/dl, p&lt;0.001). SCH + DM patients had\nsignificantly higher HbA1c levels (8.9 \u00b1 1.1 versus 7.6 \u00b1 1.3%, p&lt;0.001), HOMA-IR (3.9 \u00b1 0.8 versus\n2.8 \u00b1 1.0, p&lt;0.001) and UA levels (6.1 \u00b1 1.8 versus 4.8 \u00b1 1.7, p&lt;0.001). Correlation analysis\nidentified a significant direct correlation between serum UA and HOMA-IR in DM + SCH patients\n(r=0.4,p=0.004). In univariate analysis, presence of SCH [OR (95% CI): 2.57 (1.07-6.15),\np=0.034] and nephropathy [OR (95% CI): 4.57 (1.77-11.8), p=0.002] was significant predictors of\nhigher (upper tertile) UA in the studied patients. However, in multivariate analysis, only nephropathy\n[OR (95% CI): 4.25 (1.62-11.17), p=0.003] continued to be significant while SCH showed a\nmarginal trend [OR (95% CI): 0.43 (0.17-1.08), p=0.073].<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions:<\/jats:title>\n<jats:p>The present study suggests an association between SCH and increased UA levels in\ndiabetic patients.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1871530321666211018120419","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T04:21:55Z","timestamp":1634703715000},"page":"532-538","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relation Between URIC Acid Levels and Subclinical Hypothyroidism in\nDiabetic Patients"],"prefix":"10.2174","volume":"22","author":[{"given":"Hosameldeen S.","family":"Shabana","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Allam","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef A.","family":"Nassar","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amgad","family":"Awad","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdy M.","family":"Naguib","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelaleem A.","family":"Elgendy","sequence":"additional","affiliation":[{"name":"Department of Clinical\nPathology, Faculty of Medicine, Al-Azhar University, Cairo, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Essam","family":"Elmahdi","sequence":"additional","affiliation":[{"name":"Department of Internal medicine, Faculty of\nMedicine, Mansoura University, Mansoura, Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cjca.2018.03.002","volume":"34","author":"Weisman A.","year":"2018","unstructured":"Weisman A.; Fazli G.S.; Johns A.; Booth G.L.; Evolving trends in the epidemiology, risk factors, and prevention of type 2 diabetes: A review. Can J Cardiol 2018,34(5),552-564","journal-title":"Can J Cardiol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"Harding J.L.","year":"2019","unstructured":"Harding J.L.; Pavkov M.E.; Magliano D.J.; Shaw J.E.; Gregg E.W.; Global trends in diabetes complications: A review of current evidence. Diabetologia 2019,62(1),3-16","journal-title":"Diabetologia"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1007\/s13300-019-00700-4","volume":"10","author":"Kalra S.","year":"2019","unstructured":"Kalra S.; Aggarwal S.; Khandelwal D.; Thyroid dysfunction and type 2 diabetes mellitus: Screening strategies and implications for management. Diabetes Ther 2019,10(6),2035-2044","journal-title":"Diabetes Ther"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/DMSO.S181470","volume":"12","author":"Talwalkar P.","year":"2019","unstructured":"Talwalkar P.; Deshmukh V.; Bhole M.; Prevalence of hypothyroidism in patients with type 2 diabetes mellitus and hypertension in India: A cross-sectional observational study. Diabetes Metab Syndr Obes 2019,12,369-376","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3904\/kjim.2015.198","volume":"31","author":"Cho J.H.","year":"2016","unstructured":"Cho J.H.; Kim H.J.; Lee J.H.; Park I.R.; Moon J.S.; Yoon J.S.; Lee I.K.; Won K.C.; Lee H.W.; Poor glycemic control is associated with the risk of subclinical hypothyroidism in patients with type 2 diabetes mellitus. Korean J Intern Med (Korean Assoc Intern Med) 2016,31(4),703-711","journal-title":"Korean J Intern Med (Korean Assoc Intern Med)"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"e0135233","DOI":"10.1371\/journal.pone.0135233","volume":"10","author":"Han C.","year":"2015","unstructured":"Han C.; He X.; Xia X.; Li Y.; Shi X.; Shan Z.; Teng W.; Subclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis. PLoS One 2015,10(8),e0135233","journal-title":"PLoS One"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11739-019-02065-9","volume":"15","author":"Desideri G.","year":"2020","unstructured":"Desideri G.; Bocale R.; D\u2019Amore A.M.; Carnassale G.; Necozione S.; Barini A.; Barini A.; Lombardi C.P.; Thyroid hormones modulate uric acid metabolism in patients with recent onset subclinical hypothyroidism by improving insulin sensitivity. Intern Emerg Med 2020,15(1),67-71","journal-title":"Intern Emerg Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5935\/0101-2800.20160065","volume":"38","author":"Fouad M.","year":"2016","unstructured":"Fouad M.; Fathy H.; Zidan A.; Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients. J Bras Nefrol 2016,38(4),403-410","journal-title":"J Bras Nefrol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti K.G.","year":"2009","unstructured":"Alberti K.G.; Eckel R.H.; Grundy S.M.; Zimmet P.Z.; Cleeman J.I.; Donato K.A.; Fruchart J.C.; James W.P.; Loria C.M.; Smith S.C.; Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009,120(16),1640-1645","journal-title":"Circulation"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"e000834","DOI":"10.1136\/bmjdrc-2019-000834","volume":"8","author":"Keerman M.","year":"2020","unstructured":"Keerman M.; Yang F.; Hu H.; Wang J.; Wang F.; Li Z.; Yuan J.; Yao P.; Zhang X.; Guo H.; Yang H.; He M.; Mendelian randomization study of serum uric acid levels and diabetes risk: Evidence from the Dongfeng-Tongji cohort. BMJ Open Diabetes Res Care 2020,8(1),e000834","journal-title":"BMJ Open Diabetes Res Care"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/1753-0407.13039","volume":"12","author":"Wu M.","year":"2020","unstructured":"Wu M.; Huang X.; Yan D.; Pan H.; Li F.; Ren M.; Zhang J.; Xu M.; Interactions among endotoxin, uric acid, and lactate in relation to the risk of type 2 diabetes: A population-based study. J Diabetes 2020,12(8),605-615","journal-title":"J Diabetes"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"9637365","DOI":"10.1155\/2020\/9637365","volume":"2020","author":"Lou Y.","year":"2020","unstructured":"Lou Y.; Qin P.; Wang C.; Ma J.; Peng X.; Xu S.; Chen H.; Zhao D.; Wang L.; Liu D.; Li Y.; Zhao P.; Han D.; Hu D.; Hu F.; Sex-specific association of serum uric acid level and change in Hyperuricemia status with risk of type 2 diabetes mellitus: A large cohort study in China. J Diabetes Res 2020,2020,9637365","journal-title":"J Diabetes Res"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.2147\/DMSO.S273387","volume":"13","author":"Chen N.","year":"2020","unstructured":"Chen N.; Muhammad I.F.; Li Z.; Nilsson P.M.; Born\u00e9 Y.; Sex-specific associations of circulating uric acid with risk of diabetes incidence: A population-based cohort study from Sweden. Diabetes Metab Syndr Obes 2020,13,4323-4331","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12902-021-00698-6","volume":"21","author":"Ghasemi A.","year":"2021","unstructured":"Ghasemi A.; Uric acid-induced pancreatic \u03b2-cell dysfunction. BMC Endocr Disord 2021,21(1),24","journal-title":"BMC Endocr Disord"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2147\/IJGM.S273900","volume":"13","author":"Khassawneh A.H.","year":"2020","unstructured":"Khassawneh A.H.; Al-Mistarehi A.H.; Zein Alaabdin A.M.; Khasawneh L.; AlQuran T.M.; Kheirallah K.A.; Saadeh N.A.; Beni Yonis O.; Shawkat M.; Obeidat N.; Prevalence and predictors of thyroid dysfunction among type 2 diabetic patients: A case-control study. Int J Gen Med 2020,13,803-816","journal-title":"Int J Gen Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"8121395","DOI":"10.1155\/2020\/8121395","volume":"2020","author":"Sharma P.","year":"2020","unstructured":"Sharma P.; Sinha R.; Prasad A.; Mitra J.K.; Lack of association between poor glycemic control in T2DM and subclinical hypothyroidism. J Thyroid Res 2020,2020,8121395","journal-title":"J Thyroid Res"},{"key":"ref=17","author":"Chen X.","year":"2020","unstructured":"Chen X.; Deng S.; Sena C.; Zhou C.; Thaker V.V.; Relationship of TSH levels with cardiometabolic risk factors in US youth and reference percentiles for thyroid function. J Clin Endocrinol Metab 2020","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fendo.2019.00303","volume":"10","author":"Xu C.","year":"2019","unstructured":"Xu C.; Zhou L.; Wu K.; Li Y.; Xu J.; Jiang D.; Gao L.; Abnormal Glucose Metabolism and Insulin Resistance Are Induced via the IRE1\u03b1\/XBP-1 Pathway in Subclinical Hypothyroidism. Front Endocrinol (Lausanne) 2019,10,303","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1097\/JCMA.0000000000000285","volume":"83","author":"Xia Q.","year":"2020","unstructured":"Xia Q.; Zhang S.H.; Yang S.M.; Zhu X.L.; Su S.; Hu A.P.; Zhu J.; Li D.M.; Serum uric acid is independently associated with diabetic nephropathy but not diabetic retinopathy in patients with type 2 diabetes mellitus. J Chin Med Assoc 2020,83(4),350-356","journal-title":"J Chin Med Assoc"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"300060520963980","DOI":"10.1177\/0300060520963980","volume":"48","author":"Hou L.","year":"2020","unstructured":"Hou L.; Shi Y.; Wang S.; Chen Q.; Li Q.; Zhao M.; Zhou X.; Associations of serum uric acid level with diabetic retinopathy and albuminuria in patients with type 2 diabetes mellitus. J Int Med Res 2020,48(12),300060520963980","journal-title":"J Int Med Res"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"e10691","DOI":"10.7717\/peerj.10691","volume":"9","author":"Hu Y.","year":"2021","unstructured":"Hu Y.; Li Q.; Min R.; Deng Y.; Xu Y.; Gao L.; The association between serum uric acid and diabetic complications in patients with type 2 diabetes mellitus by gender: A cross-sectional study. PeerJ 2021,9,e10691","journal-title":"PeerJ"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.numecd.2020.04.016","volume":"30","author":"Oliveira I.O.","year":"2020","unstructured":"Oliveira I.O.; Mintem G.C.; Oliveira P.D.; Freitas D.F.; Brum C.B.; Wehrmeister F.C.; Gigante D.P.; Horta B.L.; Menezes A.M.B.; Uric acid is independent and inversely associated to glomerular filtration rate in young adult Brazilian individuals. Nutr Metab Cardiovasc Dis 2020,30(8),1289-1298","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"21672","DOI":"10.1038\/s41598-020-77702-x","volume":"10","author":"Joo H.J.","year":"2020","unstructured":"Joo H.J.; Kim G.R.; Choi D.W.; Joo J.H.; Park E.C.; Uric acid level and kidney function: A cross-sectional study of the Korean national health and nutrition examination survey (2016-2017). Sci Rep 2020,10(1),21672","journal-title":"Sci Rep"},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2020.10.006","author":"Mart\u00ednez-S\u00e1nchez F.D.","year":"2020","unstructured":"Mart\u00ednez-S\u00e1nchez F.D.; Vargas-Abonce V.P.; Guerrero-Castillo A.P.; Santos-Villavicencio M.L.; Eseiza-Acevedo J.; Meza-Arana C.E.; Gulias-Herrero A.; G\u00f3mez-S\u00e1mano M.; Serum Uric Acid concentration is associated with insulin resistance and impaired insulin secretion in adults at risk for Type 2 Diabetes. Prim Care Diabetes 2020","journal-title":"Prim Care Diabetes"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"664","DOI":"10.21037\/apm-20-2609","volume":"10","author":"Li L.","year":"2021","unstructured":"Li L.; Shi Z.; Ma L.; Lu Y.; Analysis of the correlation between plasma coagulation factor VII, PAI-1, and uric acid with insulin resistance and macrovascular complications in elderly patients with type 2 diabetes. Ann Palliat Med 2021,10(1),664-671","journal-title":"Ann Palliat Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fendo.2020.00577","volume":"11","author":"Chen J.","year":"2020","unstructured":"Chen J.; Ge J.; Zha M.; Miao J.J.; Sun Z.L.; Yu J.Y.; Effects of uric acid-lowering treatment on glycemia: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 2020,11,577","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530321666211018120419","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/197312\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1871530321666211018120419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T16:01:55Z","timestamp":1693238515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/197312\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871530321666211018120419","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-03-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-02","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}